Medline Inc. Leases Disclosure
Year ended | |||||||||||||||||
(in millions) | December 31, 2025 | December 31, 2024 | December 31, 2023 | ||||||||||||||
| Operating lease cost | $ | 106 | $ | 90 | $ | 67 | |||||||||||
| Variable lease cost | 31 | 25 | 19 | ||||||||||||||
| Short-term lease cost | 4 | 3 | 2 | ||||||||||||||
| Total lease cost | $ | 141 | $ | 118 | $ | 88 | |||||||||||
| Sublease income | (12) | (10) | (7) | ||||||||||||||
| Total lease cost, net | $ | 129 | $ | 108 | $ | 81 | |||||||||||
(in millions) | Consolidated Balance Sheets captions: | December 31, 2025 | December 31, 2024 | |||||||||||
| Operating leases: | ||||||||||||||
| Operating lease right-of-use assets | $ | 432 | $ | 384 | ||||||||||
| Current portion of operating lease liabilities | 66 | 76 | ||||||||||||
| Long-term operating lease liabilities | 386 | 329 | ||||||||||||
| Total operating lease liabilities | $ | 452 | $ | 405 | ||||||||||
The Company’s operating leases have a weighted-average remaining lease term of 7 years for both December 31, 2025 and 2024. The weighted-average discount rate of the Company’s operating leases is 7% and 8% for December 31, 2025 and 2024, respectively.
(in millions) | Total | ||||
| 2026 | $ | 92 | |||
| 2027 | 85 | ||||
| 2028 | 77 | ||||
| 2029 | 66 | ||||
| 2030 | 56 | ||||
| Thereafter | 215 | ||||
| Total future lease payments | $ | 591 | |||
| Less: Imputed interest | (139) | ||||
| Present value of future lease payments | $ | 452 | |||
Year ended | |||||||||||||||||
(in millions) | December 31, 2025 | December 31, 2024 | December 31, 2023 | ||||||||||||||
| Operating lease income | $ | 15 | $ | 13 | $ | 15 | |||||||||||
| Variable lease income | 2 | 2 | 2 | ||||||||||||||
| Total lease income | $ | 17 | $ | 15 | $ | 17 | |||||||||||
(in millions) | Total | ||||
| 2026 | $ | 13 | |||
| 2027 | 10 | ||||
| 2028 | 8 | ||||
| 2029 | 7 | ||||
| 2030 | 7 | ||||
| Thereafter | 9 | ||||
| Total future lease receivables | $ | 54 | |||
(in millions) | December 31, 2025 | December 31, 2024 | |||||||||
| Buildings and improvements | $ | 92 | $ | 110 | |||||||
| Land and improvements | 35 | 41 | |||||||||
| Less: Accumulated depreciation | (22) | (23) | |||||||||
| Assets under operating leases, net | $ | 105 | $ | 128 | |||||||
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.